Development and validation of a model to predict tyrosine kinase inhibitor-sensitive EGFR mutations of non-small cell lung cancer based on multi-institutional data. [electronic resource]
Producer: 20190813Description: 1680-1686 p. digitalISSN:- 1759-7714
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Non-Small-Cell Lung -- diagnosis
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- genetics
- Female
- Humans
- Lung Neoplasms -- diagnosis
- Male
- Middle Aged
- Models, Theoretical
- Mutation
- Neoplasm Staging
- Odds Ratio
- Prognosis
- Protein Kinase Inhibitors -- pharmacology
- ROC Curve
- Reproducibility of Results
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.